Prevalence of psychotropic and anticonvulsant drug use among North Dakota group home residents.

Christian et al. (1997) counted psychoactive prescriptions in North Dakota group homes. They asked managers for medication lists of every resident with intellectual disability.

The team wanted a simple snapshot. No pills were changed. They just tallied how many people took antipsychotics, mood pills, or seizure drugs.

Four out of ten residents were on at least one psychoactive drug. The number matched an earlier state survey, so the rate stayed steady.

Antipsychotics and anticonvulsants topped the list. Staff reported these meds were common, everyday practice.

Branford (1997) found the same year that moving people from large institutions to small homes did not cut drug use. Together the two studies show location change alone is not enough.

Fahmie et al. (2013) later surveyed over four thousand New York adults and saw fifty-eight percent on psychotropics. The higher rate suggests prescribing kept climbing after 1997, especially when doctors target diagnosed psychiatric disorders.

Cerutti et al. (2004) tracked community adults for seventeen months and saw multiple psychoactive drugs per person rising. Their data update the 1997 snapshot with a clear warning: polypharmacy keeps growing.

Use the thirty-eight percent figure as your first benchmark. When you review a new client’s med list, ask, 'Is this above or below the 1997 group-home average?' If it is above, request a physician check and document behavioral reasons in plain language. This simple comparison gives you data to back nurse calls, team meetings, and parent talks.